tirzepatide natural substitute GLP-1 Supplements: Do They Work? 9 Mounjaro Alternatives for Weight

Feb 8, 2026 Before you start researching cagrilintide, there is something you need to know

Your provider may adjust this timeline based on how youre responding

She specializes in hormone therapy, peptide therapy, and medical weight loss, using evidence-based protocols to restore metabolic function and optimize long-term health.

Retrieved February 8, 2024, from [6] Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH [7] Akero Therapeutics Reports Statistically Significant Histological Improvements at Week 96 in Phase 2b HARMONY Study [8] Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH [9] Merck to Present Data for Efinopegdutide (MK-6024), an Investigational GLP-1/Glucagon Receptor Co-agonist, in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) at EASL 2023 [10] Already rolling in diabetes and obesity, Eli Lilly touts tirzepatide's midstage MASH win [11] Survodutide Phase II trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis

As demand for GLP-1s continues to surge, companies must confront this difficulty head-on and find solutions to various engineering and operational hurdles